Precipio Announces Q1-2020 Corporate Update Call For Shareholders
May 12, 2020 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., May 12, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19th at...
Precipio Launches New HemeScreen™ Reagent Rental Program
April 06, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 06, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program....
Company Update During the COVID-19 Era
March 20, 2020 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 20, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), released today the following letter to shareholders from its CEO, Ilan Danieli. ...
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
March 16, 2020 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of...
Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool
February 26, 2020 11:30 ET
|
Precipio, Inc.
Groundbreaking clinical and economic impact to be generated NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that...
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership
February 18, 2020 10:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it is in advanced discussions with Poplar Healthcare to...
Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing
January 28, 2020 07:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide an explanation on the recent Amendment...
Precipio Provides Clarification To Recent S-1 Filing
January 15, 2020 07:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 15, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide several clarification points related to...
Precipio announces shareholder update call to kick off 2020
January 13, 2020 17:00 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that on Monday, January 20th at 5pm it will conduct a shareholder update...
First Substantial Customer: Tennessee Oncology Internalizes Precipio’s HemeScreen™
September 30, 2019 11:10 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that Tennessee Oncology has selected Precipio’s HemeScreen RUO assay as...